CAT No: CP26318
CAS No: 133464-27-4
Synonyms/Alias: 133464-27-4;Boc-D-Glu(Ochex)-Oh;(R)-2-((tert-Butoxycarbonyl)amino)-5-(cyclohexyloxy)-5-oxopentanoicacid;Boc-L-glutamicacid5-cyclohexylester;AC1Q1MU0;CTK8B7900;MolPort-005-938-127;ZINC2555005;6089AA;ANW-58898;VA50075;AC-19269;AJ-39666;AK-58080;Boc-D-glutamicacidgamma-cyclohexylester;KB-209686;RT-011730;K-4194;I14-37163;D-Glutamicacid,N-[(1,1-dimethylethoxy)carbonyl]-,5-cyclohexylester
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C16H27NO6 |
M.W/Mr. | 329.39 |
Size | 1 g;5 g;25 g; |
InChI | 1S/C16H27NO6/c1-16(2,3)23-15(21)17-12(14(19)20)9-10-13(18)22-11-7-5-4-6-8-11/h11-12H,4-10H2,1-3H3,(H,17,21)(H,19,20)/t12-/m1/s1 |
InChI Key | FDNMLANBNJDIRG-GFCCVEGCSA-N |
Canonical SMILES | CC(C)(C)OC(=O)NC(CCC(=O)OC1CCCCC1)C(=O)O |
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.